Industry perspective

2:05 PM - 2:20 PM

Ipsen commitment on plain language summaries

Sarah Thomas will give an overview of Ipsen’s plain language summary commitment, including how and why it was introduced. She will also discuss some of the challenges involved and key considerations in PLS development.

Laurence Rouxhet
Seeking to increase accessibility and patient centricity, GSK started developing plain language summaries of manuscripts and posters in 2018, testing different approaches and formats over time. A guidance to align PLS practices across the organization is under development. Key questions guiding the development of PLS at GSK are:

  • What is the intent?
  • Who is the target audience?
  • What is the appropriate content?
  • What format is best to maximize impact?